SD-OCT provides better quality images of chorodial osteoma

Article

Spectral domain-optical coherence tomography (SD-OCT) provides higher resolution images of chorodial osteoma compared with time domain-OCT, reveals a study published in the British Journal of Ophthalmology.

Spectral domain-optical coherence tomography (SD-OCT) provides higher resolution images of chorodial osteoma compared with time domain-OCT, reveals a study published in the British Journal of Ophthalmology.

Dr Paul T. Finger et al., The New York Eye Cancer Center, New York, USA, studied 11 chorodial osteoma patients in a retrospective chart review. The review included patient, clinical, ultrasonographic, photographic and SD-OCT imaging.

The results demonstrated that the mean basal diameters of tumours recorded by fundus photography and ultrasound imaging were 5.2 mm and 6.4 mm respectively. In two cases, tumours were SD-OCT hyporeflective, hyperreflective in two cases and SD-OCT isoreflective in seven cases. In four cases, the intrinsic reflectivity of the tumour was inhomogenous. Also, the remaining choroid was reduced by the tumour in eight patients. In five patients degenerative retinal changes were found.

The study gives a deeper insight into the pathophysiology and diagnosis of chorodial osteoma. The images provided by SD-OCT are deeper and are of a higher resolution compared to images provided by time domain-OCT.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.